Context Therapeutics Inc. (CNTX) stock
CNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.18−0.02 (-8.69%)
Close on Nov 13, 2026Market cap $16.61MP/E –Yield –
Context Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Context Therapeutics's enterprise value was -$23.14M on Nov 11, 2026, against $25.97M a year earlier. Over the last 5 years it ranged from -$39.53M to $207.33M, with a median of -$8.11M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$23.14M | -139.8% |
| 2025 | Dec 31, 2025 | $58.12M | – |
| 2024 | Dec 31, 2024 | -$6.05M | – |
| 2023 | Dec 29, 2023 | -$3.64M | – |
| 2022 | Dec 30, 2022 | -$29.02M | -5813.7% |
| 2021 | Dec 31, 2021 | $507.94K | – |
See a number that looks wrong?